Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schnabel

Showing results (281-290 of 346) with videos related to

Pageof 35
Sort By:
European Heart Journal|August 30, 2024
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)Isabelle C Van Gelder, Michiel Rienstra, Karina V Bunting, et al.
European Heart Journal|August 31, 2024
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule studyLarissa Fabritz, Christoph Al-Taie, Katrin Borof, et al.
International Journal of Cardiology|May 1, 2013
Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational resultsF D'Ascenzo, F Conrotto, F Giordana, et al.
Journal of the American Heart Association|March 24, 2022
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial FibrillationStephan Camen, Dora Csengeri, Bastiaan Geelhoed, et al.
Journal of the American College of Cardiology|July 3, 2024
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart DiseaseNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 24, 2024
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspectsMichiel Rienstra, Stylianos Tzeis, Karina V Bunting, et al.
European Heart Journal|January 19, 2024
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE projectNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
Circulation|November 7, 2022
Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International CollaborationAxel Brandes, Stavros Stavrakis, Ben Freedman, et al.
European Journal of Preventive Cardiology|June 12, 2025
Lipoprotein (a) and Incident Coronary Heart Disease in the Community: Impact of Traditional Cardiovascular Risk FactorsNatalie Arnold, Alina Goßling, Benjamin Bay, et al.
European Journal of Clinical Investigation|January 5, 2023
Risk prediction of atrial fibrillation and its complications in the community using hs troponin IChristin S Börschel, Bastiaan Geelhoed, Teemu Niiranen, et al.
Pageof 35

Showing results (281-290 of 346) with videos related to

Sort By:
Pageof 35
European Heart Journal|August 30, 2024
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)Isabelle C Van Gelder, Michiel Rienstra, Karina V Bunting, et al.
European Heart Journal|August 31, 2024
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule studyLarissa Fabritz, Christoph Al-Taie, Katrin Borof, et al.
International Journal of Cardiology|May 1, 2013
Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational resultsF D'Ascenzo, F Conrotto, F Giordana, et al.
Journal of the American Heart Association|March 24, 2022
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial FibrillationStephan Camen, Dora Csengeri, Bastiaan Geelhoed, et al.
Journal of the American College of Cardiology|July 3, 2024
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart DiseaseNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 24, 2024
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspectsMichiel Rienstra, Stylianos Tzeis, Karina V Bunting, et al.
European Heart Journal|January 19, 2024
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE projectNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
Circulation|November 7, 2022
Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International CollaborationAxel Brandes, Stavros Stavrakis, Ben Freedman, et al.
European Journal of Preventive Cardiology|June 12, 2025
Lipoprotein (a) and Incident Coronary Heart Disease in the Community: Impact of Traditional Cardiovascular Risk FactorsNatalie Arnold, Alina Goßling, Benjamin Bay, et al.
European Journal of Clinical Investigation|January 5, 2023
Risk prediction of atrial fibrillation and its complications in the community using hs troponin IChristin S Börschel, Bastiaan Geelhoed, Teemu Niiranen, et al.
Pageof 35